Manulife (Manufacturers Life Insurance)
CNTA

Manulife (Manufacturers Life Insurance)’s Centessa Pharmaceuticals CNTA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$555K Sell
13,965
-197,288
-93% -$5.05M ﹤0.01% 2112
2025
Q4 		$5.23M Sell
211,253
-50,893
-19% -$1.29M ﹤0.01% 1147
2025
Q3 		$6.36M Sell
262,146
-55,428
-17% -$985K 0.01% 1072
2025
Q2 		$4.17M Buy
317,574
+14,928
+5% +$189K ﹤0.01% 1246
2025
Q1 		$4.35M Sell
302,646
-14,683
-5% -$240K ﹤0.01% 1217
2024
Q4 		$5.32M Buy
317,329
+52,360
+20% +$867K ﹤0.01% 1177
2024
Q3 		$4.24M Buy
264,969
+124,075
+88% +$1.52M ﹤0.01% 1273
2024
Q2 		$1.27M Buy
140,894
+32,846
+30% +$312K ﹤0.01% 1716
2024
Q1 		$1.22M Buy
108,048
+45,027
+71% +$426K ﹤0.01% 1746
2023
Q4 		$502K Hold
63,021
– – ﹤0.01% 2167
2023
Q3 		$408K Buy
63,021
+5,600
+10% +$38.3K ﹤0.01% 2232
2023
Q2 		$355K Hold
57,421
– – ﹤0.01% 2252
2023
Q1 		$221K Hold
57,421
– – ﹤0.01% 2490
2022
Q4 		$185K Hold
57,421
– – ﹤0.01% 2604
2022
Q3 		$244K Hold
57,421
– – ﹤0.01% 2441
2022
Q2 		$287K Hold
57,421
– – ﹤0.01% 2428
2022
Q1 		$519K Buy
+57,421
New +$523K ﹤0.01% 2180

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CNTA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Centessa Pharmaceuticals (CNTA) stake by 93% in Q1 2026, selling an estimated $5.05M and leaving 13,965 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

Manulife (Manufacturers Life Insurance) first reported a position in CNTA in Q1 2022 and has held it in 17 quarters since. The position peaked at $6.36M in Q3 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 13,965 shares of Centessa Pharmaceuticals worth $555K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 197,288 Centessa Pharmaceuticals shares in Q1 2026, an estimated $5.05M.
  • Centessa Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2112 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Centessa Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Centessa Pharmaceuticals position peaked at $6.36M in Q3 2025.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.